VMD FINANCIAL STATEMENTS

Viemed Healthcare Inc — balance sheet, income statement and cash flow trends

VMDViemed Healthcare Inc

🇺🇸 USA · NASDAQ · Healthcare · Medical Devices

Value it Duel

Income Statement

Quarterly progression — trailing-twelve-month values

RevenueNet Income

Profit Funnel

Q1 2026 · TTM

Percentages are relative to revenue.

Key Figures

YoY change

Revenue286.6 M $+23.1%

Gross Profit164.3 M $+20.2%

Operating Income24 M $+22.9%

EBITDA53 M $+28.1%

Net Income14.9 M $+21.2%

Peer Comparison· Medical Devices

Company	Rev. Growth	Gross Margin	EBITDA Margin	Net Margin
VMD	23.1%	57.3%	18.5%	5.2%
SN	—	68.0%	25.6%	10.1%
4DX	-26.0%	-396.6%	-818.8%	-3,684.6%
ONCSM	39.1%	48.4%	30.6%	6.3%
MEDTR	6.5%	30.9%	9.4%	0.2%
ANGEN	11.7%	58.8%	9.8%	-45.0%
Industry median	7.4%	58.9%	5.2%	-5.7%

Company	Rev. Growth	Gross Margin	EBITDA Margin	Net Margin
VMD	23.1%	57.3%	18.5%	5.2%
KIDS	14.5%	73.1%	-2.7%	-16.3%
PACB	5.0%	37.1%	-66.6%	-80.3%
VREX	3.6%	33.6%	-0.7%	-9.6%
CLPT	26.0%	61.8%	-58.2%	-71.6%
OFIX	2.6%	69.0%	11.5%	-7.3%
Industry median	7.4%	58.9%	5.2%	-5.7%

Balance Sheet

Quarterly period-end values

Total AssetsTotal LiabilitiesEquity

Capital Structure

Q1 2026

Equity143.9 M $74%
Current Liabilities40.7 M $21%
Long-term Liabilities10.9 M $6%

Key Figures

YoY change

Total Assets197.4 M $+10.8%

Total Liabilities51.6 M $+24.8%

Total Equity143.9 M $+6.8%

Cash & ST Investments9.8 M $-3.9%

Total Debt12.4 M $+84.0%

Net Debt2.7 M $—

Peer Comparison· Medical Devices

Company	Current Ratio	Debt/Equity	NetDebt/EBITDA	Equity/Assets
VMD	1.22	8.6%	0.05	72.9%
SN	2.57	62.9%	1.72	50.6%
4DX	6.57	-22.6%	0.71	-20.4%
ONCSM	2.25	35.0%	0.42	56.4%
MEDTR	3.58	1.0%	-1.64	83.0%
ANGEN	2.31	28.1%	4.71	67.2%
Industry median	3.28	44.7%	0.82	49.7%

Company	Current Ratio	Debt/Equity	NetDebt/EBITDA	Equity/Assets
VMD	1.22	8.6%	0.05	72.9%
KIDS	5.21	31.4%	-8.36	67.4%
PACB	5.65	29,729.0%	-4.01	0.3%
VREX	3.20	80.3%	-47.21	43.5%
CLPT	5.79	337.5%	-1.18	20.2%
OFIX	2.87	53.9%	1.21	49.1%
Industry median	3.28	44.7%	0.82	49.7%

Cash Flow Statement

Quarterly progression — trailing-twelve-month values

Operating Cash FlowCapital ExpendituresFree Cash Flow

Cash Flow Bridge

Q1 2026 · TTM

Key Figures

YoY change

Operating Cash Flow57.1 M $+40.1%

Capital Expenditures31.2 M $-33.9%

Free Cash Flow25.9 M $—

Dividends Paid——

Peer Comparison· Medical Devices

Company	CF Margin	FCF Margin	CapEx Ratio	CF/Net Income
VMD	19.9%	9.0%	10.9%	383.7%
SN	20.8%	13.8%	7.0%	205.6%
4DX	-761.6%	-530.7%	3.7%	20.7%
ONCSM	6.2%	-5.5%	12.0%	99.3%
MEDTR	21.1%	27.9%	6.6%	10,700.8%
ANGEN	40.2%	-21.2%	61.5%	-89.3%
Industry median	7.2%	1.5%	4.1%	76.6%

Company	CF Margin	FCF Margin	CapEx Ratio	CF/Net Income
VMD	19.9%	9.0%	10.9%	383.7%
KIDS	-1.6%	-5.2%	3.6%	10.0%
PACB	-69.9%	-72.6%	2.8%	87.0%
VREX	-0.2%	-3.6%	3.4%	2.4%
CLPT	-63.3%	-65.8%	2.4%	88.5%
OFIX	4.2%	-0.4%	4.7%	-58.2%
Industry median	7.2%	1.5%	4.1%	76.6%

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on VMD

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 6, 26. This content is for informational purposes only and is not investment advice.